The Royal College of Pathologists , The Royal College of Pathologists, 2 Carlton House Terrace, London, UK
Thursday, 21 March 2013
Mycobacterium tuberculosis is one of the most successful human pathogens. Treatment of tuberculosis requires a long duration time with the use of multiple drugs. There is also an alarming emergence of multidrug resistant M. tuberculosis. As a result a need have arisen to develop novel anti-tubercular agents. This EuroSciCon meeting will present cutting-edge research on developments in the detection and treatment of tuberculosis.
|
|
|
Invited Speakers:
|
|
Dr. Sanjib Bhakta, Birkbeck, University of London, London , United Kingdom Professor Brian Henderson, Eastman Dental Institute, London, UK Christopher Granger, Director, Global Professional Relations, Oxford Immunotec Ltd, Abingdon,United Kingdom Dr Luke Alderwick, Director of the Birmingham Drug Discovery and Screening Facility, University of Birmingham, UK Professor Edith Sim, Dean of the Faculty of Science Engineering and Computing at Kingston University, Kingston University, Surrey, UK Professor Graham Bothamley, Homerton University Hospital, London, UK Professor Mike Barer, Professor of Clinical Microbiology, University of Leicester, UK Dr Timothy McHugh, Centre for Clinical Microbiology, UCL, UK
|
|